35 completed, 5 terminated, 3 unknown, 1 active not recruiting. 13 Phase 1, 12 Phase 4, 7 Not applicable, 7 Phase 2, 7 Phase 3.
Follow benazepril: new trials by email Literature Review of benazepril trials Research Report on benazepril
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD) Finerenone, Semaglutide, Lotensin - Chronic Kidney Disease, Type 2 Diabetes | Phase 4 | Enrolling by invitation | Baylor Research Institute | 64 | 2026-04-08 | 2026-10-13 |
| Centrally Acting ACE Inhibition in SLE Lisinopril Pills, Benazepril Pill - Systemic Lupus Erythematosus | Phase 2 | Active not recruiting | Northwell Health | 36 | 2021-10-01 | 2025-09-19 |
| Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS) Hydroxychloroquine Sulfate 100 milligram (mg) Tab, Benazepril hydrochloride 10 milligram (mg) Tab - Alport Syndrome, X-Linked | Phase 2 | Completed | Shanghai Children's Hospital | 50 | 2021-09-08 | 2026-03-02 |
| Coronavirus (COVID-19) ACEi/ARB Investigation Thiazide or Thiazide-like diuretics, Calcium Channel Blockers, ACE inhibitor - Hypertension, COVID-19 | Phase 4 | Suspended | National University of Ireland, Galway, Ireland | 2414 | 2020-04-30 | 2020-06-30 |
| ACEI or ARB and COVID-19 Severity and Mortality in US Veterans ACEI/ARB, Non-ACEI/ARB, ACEI - Hypertension, COVID | Completed | University of Utah | 22213 | 2020-01-19 | 2021-04-28 | |
| The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children Prednisone, ACEI - Henoch-Schoenlein Purpura Nephritis | Phase 2 | Unknown | Nanjing Children's Hospital | 100 | 2015-08-01 | 2020-02-26 |
| The Research of Standard Diagnosis and Treatment for HSPN in Children Prednisone, Cyclophosphamide(CTX), Mycophenolate mofetil(MMF) - Henoch-Schoenlein Purpura Nephritis | Phase 2 | Unknown | Nanjing Children's Hospital | 100 | 2015-08-01 | 2020-02-26 |
| Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery ACEI continuation, ACEI omission - Hypotension on Induction | Phase 4 | Completed | University of Nebraska | 291 | 2015-06-01 | 2023-09-25 |
| Study on Children Henoch-Schönlein Purpura Nephritis With TCM Multistep Treatment Glycosides Of Tripterygium Wilfordii Hook(GTW), Sulfotanshinone Sodium Injection, Chinese herbs based on syndrome differentiation - Henoch-Schönlein Purpura Nephritis | Phase 1 / Phase 2 | Unknown | Henan University of Traditional Chinese Medicine | 500 | 2014-09-01 | 2018-07-19 |
| Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine Benazepril, Losartan - Hypertension, Diabetes Mellitus | Phase 4 | Completed | Hospital Universitario Pedro Ernesto | 30 | 2012-05-01 | 2016-02-01 |
| Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors lisinopril, losartan potassium, laboratory biomarker analysis - Hypertension, Unspecified Adult Solid Tumor, Protocol Specific | Phase 2 | Terminated | Wake Forest University Health Sciences | 6 | 2011-02-01 | 2018-08-28 |
| Post-preeclampsia Renal Project: Study of Nephroprotection in Women Having Suffered Preeclampsia Placebo, Benazepril hydrochloride - Renal Alteration | Phase 3 | Completed | University Hospital, Geneva | 120 | 2010-04-01 | 2018-05-01 |
| Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients Benazepril, Valsartan, Benazepril+Valsartan - Renal Function Disorder | Not applicable | Completed | Sun Yat-sen University | 200 | 2008-09-01 | 2015-05-20 |
| Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency Benazepril, Losartan, Benazepril+Losartan - Renal Insufficiency, Chronic | Not applicable | Terminated | Nanfang Hospital, Southern Medical University | 309 | 2008-02-01 | 2016-04-05 |
| ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria Amlodipine+Benazepril, Valsartan+Hydrochlorothiazide - Hypertension, Diabetes Mellitus, Type 2 | Phase 4 | Completed | TSH Biopharm Corporation Limited | 226 | 2007-06-01 | 2011-06-17 |
| Preventing ESRD in Overt Nephropathy of Type 2 Diabetes Benazepril, Valsartan, Benazepril/Valsartan - Diabetes | Phase 3 | Completed | Mario Negri Institute for Pharmacological Research | 102 | 2007-05-01 | 2016-06-01 |
| Preventing Microalbuminuria in Type 2 Diabetes Benazepril, Valsartan, Benazepril/Valsartan - Diabetes | Phase 3 | Completed | Mario Negri Institute for Pharmacological Research | 612 | 2007-05-01 | 2019-09-06 |
| Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fasting Conditions Amlodipine Besylate/Benazepril HCl - Fasting | Phase 1 | Completed | Dr. Reddy's Laboratories Limited | 50 | 2007-03-01 | 2012-01-09 |
| Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Conditions Amlodipine Besylate/Benazepril HCl - Fed | Phase 1 | Completed | Dr. Reddy's Laboratories Limited | 49 | 2007-03-01 | 2012-01-09 |
| Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension Benazepril plus hydrochlorothiazide - Hypertension | Phase 3 | Completed | Novartis | 296 | 2006-07-01 | 2007-07-09 |
Showing 20 of 46. Sign in to see all of them.
Hypertension (15) · Diabetes Mellitus (6) · Diabetes Mellitus, Type 2 (4) · Albuminuria (3) · Renal Insufficiency, Chronic (3) · Cardiovascular Diseases (2) · Nephritis, Hereditary (2) · Proteinuria (2) · Atherosclerosis (1) · COVID-19 (1) · Cardiomyopathy, Dilated (1) · Coronary Disease (1) · Coronavirus Infections (1) · Diabetic Nephropathies (1) · Disease Progression (1)
Novartis (6) · Dr. Reddy's Laboratories Limited (4) · Mylan Pharmaceuticals Inc (4) · Teva Pharmaceuticals USA (4) · Mario Negri Institute for Pharmacological Research (3) · Nanjing Children's Hospital (2) · Ranbaxy Laboratories Limited (2) · Southern Medical University, China (2) · Abbott (1) · Baylor Research Institute (1) · Charles Drew University of Medicine and Science (1) · Daiichi Sankyo (1) · Henan University of Traditional Chinese Medicine (1) · Hospital Universitario Pedro Ernesto (1) · Nanfang Hospital, Southern Medical University (1)
United States (21) · China (9) · Canada (3) · Italy (3) · India (2) · Brazil (1) · Denmark (1) · Finland (1) · Ireland (1) · Norway (1) · Slovenia (1) · Sweden (1) · Switzerland (1) · Taiwan (1)
Fan Fan Hou, M.D.,Ph.D. (3) · Aihua Zhang, M.D. (2) · Dorian Williams, M.D. (2) · Gaetano Morelli, M.D (2) · I. S. Gandhi., MD (2) · Richard Larouche, M.D. (2) · Adam P Bress, PharmD, MS (1) · Denise Simons-Morton, MD, PhD (1) · Erica Daina, MD (1) · Fei Xiong, M.D. (1) · Giuseppe Remuzzi, MD (1) · Hao Zhang, M.D. (1)
PMID 36853224, PMID 16407508, PMID 18539917, PMID 18776118, PMID 19052124, PMID 19687350, PMID 19890370, PMID 19898642, PMID 20061358, PMID 20061360, PMID 20170948, PMID 20215456, PMID 20228401, PMID 20228404, PMID 20427682, PMID 20571135, PMID 20587587, PMID 20594588, PMID 20620720, PMID 21366473, PMID 21663644, PMID 21958949, PMID 22019270, PMID 22049171, PMID 22179956, PMID 22374637, PMID 22432114, PMID 22450889, PMID 22515638, PMID 22619083, PMID 22646230, PMID 22723577, PMID 22784975, PMID 23033246, PMID 23219284, PMID 23238658, PMID 23412077, PMID 23990163, PMID 24170759, PMID 24296848, PMID 24493100, PMID 24595629, PMID 24779562, PMID 25088437, PMID 25127725, PMID 25159234, PMID 25172198, PMID 25193529, PMID 25229335, PMID 25267796
N01HC95178 (1), N01HC95179 (1), N01HC95180 (1), N01HC95181 (1), N01HC95182 (1), N01HC95183 (1), N01HC95184 (1), U54RR014616 (1)